Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Schneck

Showing results (121-130 of 165) with videos related to

Pageof 17
Sort By:
The Journal of Experimental Medicine|October 23, 1997
Analysis of the expression of peptide-major histocompatibility complexes using high affinity soluble divalent T cell receptorsS M O'Herrin, M S Lebowitz, J G Bieler, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 17, 2015
CD47 Enhances In Vivo Functionality of Artificial Antigen-Presenting CellsHeiko Bruns, Catherine Bessell, Juan Carlos Varela, et al.
Glycobiology|July 16, 2008
Lectin microarrays identify cell-specific and functionally significant cell surface glycan markersSheng-Ce Tao, Yu Li, Jiangbing Zhou, et al.
Scientific Reports|January 19, 2016
Cytotoxic polyfunctionality maturation of cytomegalovirus-pp65-specific CD4 + and CD8 + T-cell responses in older adults positively correlates with response sizeYen-Ling Chiu, Chung-Hao Lin, Bo-Yi Sung, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 15, 2016
VEGF Potentiates GD3-Mediated Immunosuppression by Human Ovarian Cancer CellsIrina V Tiper, Sarah M Temkin, Sarah Spiegel, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 18, 2001
Antigen-specific blockade of T cells in vivo using dimeric MHC peptideS M O'Herrin, J E Slansky, Q Tang, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 15, 1993
A soluble divalent class I major histocompatibility complex molecule inhibits alloreactive T cells at nanomolar concentrationsJ Dal Porto, T E Johansen, B Catipović, et al.
The American Journal of Pathology|June 27, 2007
Protection from autoimmune diabetes and T-cell lymphoproliferation induced by FasL mutation are differentially regulated and can be uncoupled pharmacologicallyAbdiaziz S Mohamood, Mehmet L Guler, Zuoxiang Xiao, et al.
Oncogene|March 16, 1995
Abnormal B-cell function in HTLV-I-tax transgenic miceR S Peebles, C R Maliszewski, T A Sato, et al.
AIDS Research and Human Retroviruses|August 13, 1999
An algorithm for evaluating human cytotoxic T lymphocyte responses to candidate AIDS vaccinesL M Carruth, T F Greten, C E Murray, et al.
Pageof 17

Showing results (121-130 of 165) with videos related to

Sort By:
Pageof 17
The Journal of Experimental Medicine|October 23, 1997
Analysis of the expression of peptide-major histocompatibility complexes using high affinity soluble divalent T cell receptorsS M O'Herrin, M S Lebowitz, J G Bieler, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 17, 2015
CD47 Enhances In Vivo Functionality of Artificial Antigen-Presenting CellsHeiko Bruns, Catherine Bessell, Juan Carlos Varela, et al.
Glycobiology|July 16, 2008
Lectin microarrays identify cell-specific and functionally significant cell surface glycan markersSheng-Ce Tao, Yu Li, Jiangbing Zhou, et al.
Scientific Reports|January 19, 2016
Cytotoxic polyfunctionality maturation of cytomegalovirus-pp65-specific CD4 + and CD8 + T-cell responses in older adults positively correlates with response sizeYen-Ling Chiu, Chung-Hao Lin, Bo-Yi Sung, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 15, 2016
VEGF Potentiates GD3-Mediated Immunosuppression by Human Ovarian Cancer CellsIrina V Tiper, Sarah M Temkin, Sarah Spiegel, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 18, 2001
Antigen-specific blockade of T cells in vivo using dimeric MHC peptideS M O'Herrin, J E Slansky, Q Tang, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 15, 1993
A soluble divalent class I major histocompatibility complex molecule inhibits alloreactive T cells at nanomolar concentrationsJ Dal Porto, T E Johansen, B Catipović, et al.
The American Journal of Pathology|June 27, 2007
Protection from autoimmune diabetes and T-cell lymphoproliferation induced by FasL mutation are differentially regulated and can be uncoupled pharmacologicallyAbdiaziz S Mohamood, Mehmet L Guler, Zuoxiang Xiao, et al.
Oncogene|March 16, 1995
Abnormal B-cell function in HTLV-I-tax transgenic miceR S Peebles, C R Maliszewski, T A Sato, et al.
AIDS Research and Human Retroviruses|August 13, 1999
An algorithm for evaluating human cytotoxic T lymphocyte responses to candidate AIDS vaccinesL M Carruth, T F Greten, C E Murray, et al.
Pageof 17